Table 6.
Efficacy by genotype in recent randomized trials of standard treatments with pegylated interferon-α (PegIFNα) plus ribavirin and the novel regimens based on direct-acting antiviral agents
View large
Efficacy by genotype in recent randomized trials of standard treatments with pegylated interferon-α (PegIFNα) plus ribavirin and the novel regimens based on direct-acting antiviral agents

*Detailed references in Liang and Ghany58  and in the 2014 guidelines of the European Association for the Study of the Liver (EASL).41 

†Patients with cirrhosis were included in the trial.

View Large